NARI - Inari Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
47.75
+3.75 (+8.52%)
At close: 4:00PM EDT

46.55 -1.20 (-2.51%)
After hours: 7:23PM EDT

Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close44.00
Open44.90
Bid47.70 x 2200
Ask47.72 x 1800
Day's Range44.70 - 50.50
52 Week Range39.55 - 50.50
Volume1,202,863
Avg. Volume1,936,460
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Inari Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

      The gross proceeds to Inari, before deducting underwriting discounts and commissions and offering expenses, were approximately $179.2 million. Inari’s common stock is listed on the Nasdaq Global Select Market under the symbol "NARI."

    • Inari Medical shares soar in IPO
      Yahoo Finance Video

      Inari Medical shares soar in IPO

      Inari Medical shares soar in public debut under the ticker NARI. Yahoo Finance's Adam Shapiro discusses.

    • MarketWatch

      Inari Medical's stock blasts off, trades more than double the IPO price

      Shares of Inari Medical Inc. rocketed out of the gate Friday, as they opened for trading at prices that were more than double the initial public offering price. The Irvine, Calif.-based company, which develops medical devices for patients suffering from venous diseases, upsized its IPO to 8.20 million shares from 7.33 million shares. The company raised $155.85 million in the IPO, which priced at $19, above the expected range of $17 to $18, which was recently raised from $14 to $16. The stock's first trade was at $41.30--117% above the IPO price--at 12:09 p.m. ET for 1.1 million shares. It has since held its gains, and was most recently up 116%. The company went public at a time that the Renaissance IPO ETF has gained 2.9% over the past three months, while the S&P 500 has lost 12.0%.

    • MarketWatch

      Inari Medical increases shares it sold in IPO, which priced above the expected range

      Inari Medical Inc. increased that number of shares it was selling in its initial public offering, which priced late Thursday above the expected range. The Irvine, Calif.-based company, which develops medical devices for patients suffering from venous diseases, offered 8.2 million shares in the IPO, up from 7.33 million. The IPO priced at $19 a share, above the expected range of $17 to $18 a share, which was raised early Thursday from a previous expected range of $14 to $16. The company raised $155.85 million in the IPO. The stock is expected to begin trading on the Nasdaq exchange Friday. BofA Securities and Morgan Stanley are the joint lead bookrunning managers for the offering. The company is going public at a time that the Renaissance IPO ETF has gained 2.2% over the past three months while the S&P 500 has lost 11.7%.

    • GlobeNewswire

      Inari Medical Announces Pricing of Its Upsized Initial Public Offering

      All of the shares are being offered and sold by Inari. In addition, Inari has granted the underwriters a 30-day option to purchase up to an additional 1,230,384 shares of common stock at the initial public offering price, less underwriting discounts and commissions.